A 38-year-old woman on oral contraceptives (ethinyl estradiol + levonorgestrel) is prescribed rifampicin for newly diagnosed tuberculosis. Which of the following is the most appropriate counselling regarding contraceptive efficacy?

Explanation

## Drug Interaction: Rifampicin and Oral Contraceptives **Key Point:** Rifampicin is a potent inducer of **CYP3A4, CYP2C9, and CYP2C19**, which metabolize ethinyl estradiol and progestins. This interaction dramatically reduces OCP efficacy, increasing the risk of unintended pregnancy. ### Mechanism of Interaction 1. **Ethinyl estradiol** is metabolized by CYP3A4 (primary) and glucuronidation 2. **Progestins** (levonorgestrel, norethisterone) are metabolized by CYP3A4 and CYP2C9 3. Rifampicin **induces** these enzymes → ↑ metabolism → ↓ contraceptive hormone levels 4. Result: **Loss of ovulation suppression** and **contraceptive failure** 5. Risk period: **During TB treatment** (typically 2 months intensive phase) **and up to 4 weeks after rifampicin discontinuation** (enzyme induction persists) ### Management Strategy | Approach | Recommendation | Efficacy | |----------|-----------------|----------| | **LARC** | IUD (copper or LNG), implant, or injection | Unaffected by enzyme induction; **preferred** | | **Barrier + OCP** | Condoms + OCP during and 4 weeks after rifampicin | Reduces pregnancy risk; acceptable | | **Increased OCP dose** | Not recommended | Unpredictable; some women still ovulate | | **OCP alone** | Contraindicated | ~10–50% failure rate | **High-Yield:** Rifampicin is the **most significant enzyme inducer** in clinical practice. It affects the metabolism of >50 drugs, including OCPs, warfarin, and methadone. **Mnemonic for Enzyme Inducers: PC BRAS** — Phenytoin, Carbamazepine, Barbiturates, Rifampicin, Alcohol (chronic), St. John's Wort **Clinical Pearl:** The interaction begins within **2–3 days** of rifampicin initiation and persists for **3–4 weeks** after stopping (due to slow enzyme degradation). Contraceptive counselling must cover the entire TB treatment period plus post-treatment window. ### Why Option 2 Is Preferred - **LARC** (IUD, implant, injection): Not affected by enzyme induction; provides reliable contraception throughout TB treatment. - **Barrier methods** (condoms): Dual protection; reduces STI risk and provides backup contraception. - **Combined approach**: Addresses both efficacy and safety concerns. ### Why Other Options Fail - **Continuing same OCP** (Option 0): Contraceptive failure rate is 10–50%; unacceptable risk. - **Increasing OCP dose** (Option 1): No evidence supports higher doses; ovulation may still occur in some women. - **Discontinuing OCP entirely** (Option 3): Unnecessarily restrictive; LARC + barrier methods are more practical.